The DOI matches its Crossref record; 155 of the 155 references it cites were found in a registry or an index.
Faecal calprotectin testing for differentiating amongst inflammatory and non-inflammatory bowel diseases: systematic review and economic evaluation
Open accessAbstract
BACKGROUND: Irritable bowel syndrome (IBS) is common, and causes pain, bloating and diarrhoea and/or constipation. It is a troublesome condition that reduces the quality of life but causes no permanent damage. Inflammatory bowel disease (IBD) comprises mainly ulcerative colitis (UC) and Crohn's disease (CD). Both cause serious complications and may lead to sections of the bowel having to be removed, although this is more common with CD. The presenting symptoms of IBS and IBD can be similar. Distinguishing them on clinical signs and symptoms can be difficult. Until recently, colonoscopy was often required to rule out IBD. In younger people, > 60% of colonoscopies showed no abnormality. Faecal calprotectin (FC) is a protein released by the white blood cells, neutrophils, found in inflamed areas of the bowel in IBD. Determining the level of FC in stool samples may help distinguish IBS from IBD. OBJECTIVE: To review the value of FC for distinguishing between IBD and non-IBD. DATA SOURCES: Sources included MEDLINE, EMBASE, The Cochrane Library, Web of Science, websites of journals and the European Crohn's and Colitis Organisation (conference abstracts 2012 and 2013), and contact with experts. REVIEW METHODS: Systematic review and economic modelling. Review Manager (RevMan) version 5.2 (The Cochrane Collaboration, The Nordic Cochrane Centre, Copenhagen, Denmark) was used for most analysis, with statistical analyses done in Stata version 12 (StataCorp LP, College Station, TX, USA). Forest plots and receiver operating characteristic curves were produced. Quality Assessment of Diagnostic Accuracy Studies was used for quality assessment. Economic modelling was done in Microsoft Excel 2010 (Microsoft Corporation, Redmond, WA, USA). LIMITATIONS: Studies were often small, most used only one calprotectin cut-off level, and nearly all came from secondary care populations. RESULTS: Twenty-eight studies provided data for 2 × 2 tables and were included in meta-analyses, with seven in the most important comparison in adults (IBS vs. IBD) and eight in the key comparison in paediatrics (IBD vs. non-IBD). Most studies used laboratory enzyme-linked immunosorbent assay (ELISA) tests. For distinguishing between IBD and IBS in adults, these gave pooled sensitivity of 93% and specificity of 94% at FC cut-off level of 50 µg/g. Sensitivities at that cut-off ranged from 83% to 100%, and specificities from 60% to 100%. For distinguishing between IBD and non-IBD in paediatric populations with ELISA tests, sensitivities ranged from 95% to 100% at cut-off of 50 µg/g and specificities of 44-93%. Few studies used point-of-care testing but that seemed as reliable as ELISA, though perhaps less specific. The evidence did not provide any grounds for preferring one test over others on clinical effectiveness grounds. FC testing in primary care could reduce the need for referral and colonoscopies. Any quality-adjusted life-year gains are likely to be small because of the low prevalence of IBD and the high sensitivities of all of the tests, resulting in few false negatives with IBD. However, considerable savings could accrue. Areas of uncertainty include the optimum management of people with borderline results (50-150 µg/g), most of whom do not have IBD. Repeat testing may be appropriate before referral. CONCLUSIONS: Faecal calprotectin can be a highly sensitive way of detecting IBD, although there are inevitably trade-offs between sensitivity and specificity, with some false positives (IBS with positive calprotectin) if a low calprotectin cut-off is used. In most cases, a negative calprotectin rules out IBD, thereby sparing most people with IBS from having to have invasive investigations, such as colonoscopy. STUDY REGISTRATION: PROSPERO CRD 42012003287. FUNDING: The National Institute for Health Research Health Technology Assessment programme.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Longstreth, G. F., Thompson, W. G., Chey, W. D., Houghton, L. A., Mearin, F., & Spiller, R. C. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.061 · Cited by 4,856
Whiting, P., Rutjes, A. W., Reitsma, J. B., Bossuyt, P. M., & Kleijnen, J. (2003) · BMC Medical Research Methodology · doi:10.1186/1471-2288-3-25 · Cited by 3,592
Ford Alexander, C., Paul, M., Hanauer Steven, B., 谭蓓, & Dong, W. Z. (2001) · Cited by 3,021
(1958) · Journal of the American Pharmaceutical Association (Scientific ed.) · doi:10.1002/jps.3030470133 · Cited by 2,489
Functional bowel disorders and functional abdominal pain
Thompson, W. G., Longstreth, G. F., Drossman, D. A., Heaton, K. W., Irvine, E. J., & Müller-Lissner, S. A. (1999) · Gut · doi:10.1136/gut.45.2008.ii43 · Cited by 2,440
Epidemiology and Natural History of Inflammatory Bowel Diseases
Cosnes, J., Gower–Rousseau, C., Seksik, P., & Cortot, A. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.01.055 · Cited by 2,211
Baumgart, D. C., & Sandborn, W. J. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60026-9 · Cited by 2,154
Atkin, W. S., Edwards, R., Kralj-Hans, I., Wooldrage, K., Hart, A. R., Northover, J. M., Parkin, D. M., Wardle, J., Duffy, S. W., & Cuzick, J. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60551-x · Cited by 1,623
The Efficacy of Diagnostic Imaging
Fryback, D. G., & Thornbury, J. R. (1991) · Medical Decision Making · doi:10.1177/0272989x9101100203 · Cited by 1,291
Systematic Reviews of Diagnostic Test Accuracy
Leeflang, M. M. G., Deeks, J. J., Gatsonis, C., & Bossuyt, P. M. M. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-12-200812160-00008 · Cited by 1,124
The Natural History of Adult Crohn's Disease in Population-Based Cohorts
Peyrin-Biroulet, L., Loftus, E. V., Colombel, J.-F., & Sandborn, W. J. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2009.579 · Cited by 1,047
Shivananda, S., Lennard-Jones, J., Logan, R., Fear, N., Price, A., Carpenter, L., & van Blankenstein, M. (1996) · Gut · doi:10.1136/gut.39.5.690 · Cited by 1,028
Davidson's Principles and Practice of Medicine.
(1985) · Annals of Internal Medicine · doi:10.7326/0003-4819-103-6-973_2 · Cited by 936
Foell, D., Wittkowski, H., Vogl, T., & Roth, J. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0306170 · Cited by 879
Guidelines on the irritable bowel syndrome: mechanisms and practical management
Spiller, R., Aziz, Q., Creed, F., Emmanuel, A., Houghton, L., Hungin, P., Jones, R., Kumar, D., Rubin, G., Trudgill, N., et al. (2007) · Gut · doi:10.1136/gut.2007.119446 · Cited by 818
Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease
DʼHaens, G., Ferrante, M., Vermeire, S., Baert, F., Noman, M., Moortgat, L., Geens, P., Iwens, D., Aerden, I., Van Assche, G., et al. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.22917 · Cited by 816
A comparison of the EQ‐5D and SF‐6D across seven patient groups
Brazier, J., Roberts, J., Tsuchiya, A., & Busschbach, J. (2004) · Health Economics · doi:10.1002/hec.866 · Cited by 797
Tibble, J. A., Sigthorsson, G., Bridger, S., Fagerhol, M. K., & Bjarnason, I. (2000) · Gastroenterology · doi:10.1053/gast.2000.8523 · Cited by 759
van Rheenen, P. F., Van de Vijver, E., & Fidler, V. (2010) · BMJ · doi:10.1136/bmj.c3369 · Cited by 714
Assessment of the Neutrophil Dominating Protein Calprotectin in Feces: A Methodologic Study
RØseth, A. G., Fagerhol, M. K., Aadland, E., & Schjønsby, H. (1992) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529209011186 · Cited by 669
Langhorst, J., Elsenbruch, S., Koelzer, J., Rueffer, A., Michalsen, A., & Dobos, G. J. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01556.x · Cited by 591
Schoepfer, A. M., Beglinger, C., Straumann, A., Trummler, M., Vavricka, S. R., Bruegger, L. E., & Seibold, F. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2009.545 · Cited by 570
Complications of Colonoscopy in an Integrated Health Care Delivery System
Levin, T. R., Zhao, W., Conell, C., Seeff, L. C., Manninen, D. L., Shapiro, J. A., & Schulman, J. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-12-200612190-00004 · Cited by 552
Risk of Perforation After Colonoscopy and Sigmoidoscopy: A Population-Based Study
Gatto, N. M., Frucht, H., Sundararajan, V., Jacobson, J. S., Grann, V. R., & Neugut, A. I. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.3.230 · Cited by 522
A simple method for assessing intestinal inflammation in Crohn's disease
Tibble, J., Teahon, K., Thjodleifsson, B., Roseth, A., Sigthorsson, G., Bridger, S., Foster, R., Sherwood, R., Fagerhol, M., & Bjarnason, I. (2000) · Gut · doi:10.1136/gut.47.4.506 · Cited by 492
Sipponen, T., Savilahti, E., Kolho, K.-L., Nuutinen, H., Turunen, U., & Färkkilä, M. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20312 · Cited by 480
Adverse Events After Outpatient Colonoscopy in the Medicare Population
Warren, J. L., Klabunde, C. N., Mariotto, A. B., Meekins, A., Topor, M., Brown, M. L., & Ransohoff, D. F. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-12-200906160-00008 · Cited by 466
metandi: Meta-analysis of diagnostic accuracy using hierarchical logistic regression
Harbord, R. M., & Whiting, P. (2009) · The Stata Journal: Promoting communications on statistics and Stata · doi:10.1177/1536867x0900900203 · Cited by 453
Tibble, J. A., Sigthorsson, G., Foster, R., Forgacs, I., & Bjarnason, I. (2002) · Gastroenterology · doi:10.1053/gast.2002.34755 · Cited by 441
A. G. Røseth, P. N. S. (1999) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365529950172835 · Cited by 422
Diagnostic Precision of Fecal Calprotectin for Inflammatory Bowel Disease and Colorectal Malignancy
von Roon, A. C., Karamountzos, L., Purkayastha, S., Reese, G. E., Darzi, A. W., Teare, J. P., Paraskeva, P., & Tekkis, P. P. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01126.x · Cited by 401
British Society of Gastroenterology
Gillespie, I. E. (1964) · Gastroenterology · doi:10.1016/s0016-5085(64)80069-x · Cited by 396
Ramadas, A. V., Gunesh, S., Thomas, G. A. O., Williams, G. T., & Hawthorne, A. B. (2010) · Gut · doi:10.1136/gut.2009.202101 · Cited by 384
Røseth, A. G., Aadland, E., Jahnsen, J., & Raknerud, N. (1997) · Digestion · doi:10.1159/000201441 · Cited by 365
(2006) · Operative Pediatric Surgery 6Ed · doi:10.1201/b13237-67 · Cited by 341
Analysing and Presenting Results
Macaskill, P., Gatsonis, C., Deeks, J. J., Harbord, R., & Takwoingi, Y. (2010) · Bristol Research (University of Bristol) · Cited by 337
Schoepfer, A. M., Beglinger, C., Straumann, A., Trummler, M., Renzulli, P., & Seibold, F. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20986 · Cited by 326
SIPPONEN, T., KÄRKKÄINEN, P., SAVILAHTI, E., KOLHO, K. ‐., NUUTINEN, H., TURUNEN, U., & FÄRKKILÄ, M. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03835.x · Cited by 324
The Natural History of Pediatric Ulcerative Colitis: A Population-Based Cohort Study
Gower-Rousseau, C., Dauchet, L., Vernier-Massouille, G., Tilloy, E., Brazier, F., Merle, V., Dupas, J.-L., Savoye, G., Baldé, M., Marti, R., et al. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.177 · Cited by 313
Farrokhyar, F., Marshall, J. K., Easterbrook, B., & Irvine, J. E. (2006) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000195391.49762.89 · Cited by 310
High prevalence of NSAID enteropathy as shown by a simple faecal test
Tibble, J. A., Sigthorsson, G., Foster, R., Scott, D., Fagerhol, M. K., Roseth, A., & Bjarnason, I. (1999) · Gut · doi:10.1136/gut.45.3.362 · Cited by 307
Role of faecal calprotectin as non-invasive marker of intestinal inflammation
Costa, F., Mumolo, M. G., Bellini, M., Romano, M. R., Ceccarelli, L., Arpe, P., Sterpi, C., Marchi, S., & Maltinti, G. (2003) · Digestive and Liver Disease · doi:10.1016/s1590-8658(03)00381-5 · Cited by 289
Schoepfer, A. M., Trummler, M., Seeholzer, P., Seibold-Schmid, B., & Seibold, F. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20275 · Cited by 287
Mao, R., Xiao, Y.-L., Gao, X., Chen, B.-L., He, Y., Yang, L., Hu, P.-J., & Chen, M.-H. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.22861 · Cited by 280
Casellas, F., Arenas, J. I., Baudet, J. S., Fábregas, S., García, N., Gelabert, J., Medina, C., Ochotorena, I., Papo, M., Rodrigo, L., et al. (2005) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000159661.55028.56 · Cited by 269
Costs of Irritable Bowel Syndrome in the UK and US
Maxion-Bergemann, S., Thielecke, F., Abel, F., & Bergemann, R. (2006) · PharmacoEconomics · doi:10.2165/00019053-200624010-00002 · Cited by 263
Keohane, J., O'Mahony, C., O'Mahony, L., O'Mahony, S., Quigley, E. M., & Shanahan, F. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.156 · Cited by 253
Systematic evaluation of risk factors for diagnostic delay in inflammatory bowel disease
Vavricka, S. R., Spigaglia, S. M., Rogler, G., Pittet, V., Michetti, P., Felley, C., Mottet, C., Braegger, C. P., Rogler, D., Straumann, A., et al. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21719 · Cited by 245
Rising incidence of pediatric inflammatory bowel disease in Scotland*
Henderson, P., Hansen, R., Cameron, F. L., Gerasimidis, K., Rogers, P., Bisset, M. W., Reynish, E. L., Drummond, H. E., Anderson, N. H., Van Limbergen, J., et al. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21797 · Cited by 242
Bernklev, T., Jahnsen, J., Lygren, I., Henriksen, M., Vatn, M., & Moum, B. (2005) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000179467.01748.99 · Cited by 238
Bunn, S. K., Bisset, W. M., Main, M. J. C., Gray, E. S., Olson, S., & Golden, B. E. (2001) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1002/j.1536-4801.2001.tb07395.x · Cited by 237
Bowel Inflammation as Measured by Fecal Calprotectin
Poullis, A., Foster, R., Shetty, A., Fagerhol, M. K., & Mendall, M. A. (2004) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-03-0160 · Cited by 223
Carroccio, A., Iacono, G., Cottone, M., Di Prima, L., Cartabellotta, F., Cavataio, F., Scalici, C., Montalto, G., Di Fede, G., Rini, G., et al. (2003) · Clinical Chemistry · doi:10.1373/49.6.861 · Cited by 221
Calprotectin and lactoferrin in the assessment of intestinal inflammation and organic disease
D’Incà, R., Dal Pont, E., Di Leo, V., Ferronato, A., Fries, W., Vettorato, M. G., Martines, D., & Sturniolo, G. C. (2007) · International Journal of Colorectal Disease · doi:10.1007/s00384-006-0159-9 · Cited by 215
Kaiser, T., Langhorst, J., Wittkowski, H., Becker, K., Friedrich, A. W., Rueffer, A., Dobos, G. J., Roth, J., & Foell, D. (2007) · Gut · doi:10.1136/gut.2006.113431 · Cited by 212
Faecal calprotectin: a marker of inflammation throughout the intestinal tract
Aadland, E., & Fagerhol, M. K. (2002) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200208000-00002 · Cited by 207
Fecal Calprotectin as a Measure of Disease Activity in Childhood Inflammatory Bowel Disease
Bunn, S. K., Bisset, W. M., Main, M. J. C., & Golden, B. E. (2001) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1002/j.1536-4801.2001.tb07239.x · Cited by 205
Akehurst, R. L., Brazier, J. E., Mathers, N., O??Keefe, C., Kaltenthaler, E., Morgan, A., Platts, M., & Walters, S. J. (2002) · PharmacoEconomics · doi:10.2165/00019053-200220070-00003 · Cited by 203
Olafsdottir, E. J., Aksnes, L., FLUGE, G., & Berstad, A. (2002) · Acta Paediatrica · doi:10.1080/080352502753457932 · Cited by 200
Paré, P., Gray, J., Lam, S., Balshaw, R., Khorasheh, S., Barbeau, M., Kelly, S., & McBurney, C. R. (2006) · Clinical Therapeutics · doi:10.1016/j.clinthera.2006.10.010 · Cited by 199
Bruzzese, E., Raia, V., Gaudiello, G., Polito, G., Buccigrossi, V., Formicola, V., & Guarino, A. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.02174.x · Cited by 195
The Effects of Infliximab Therapy on Health-Related Quality of Life in Ulcerative Colitis Patients
Feagan, B. G., Reinisch, W., Rutgeerts, P., Sandborn, W. J., Yan, S., Eisenberg, D., Bala, M., Johanns, J., Olson, A., & Hanauer, S. B. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01094.x · Cited by 178
Berni Canani, R., Terrin, G., Rapacciuolo, L., Miele, E., Siani, M. C., Puzone, C., Cosenza, L., Staiano, A., & Troncone, R. (2008) · Digestive and Liver Disease · doi:10.1016/j.dld.2008.01.017 · Cited by 175
Limburg, P. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(00)01987-0 · Cited by 171
Shulman, R. J., Eakin, M. N., Czyzewski, D. I., Jarrett, M., & Ou, C.-N. (2008) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2008.04.062 · Cited by 171
An Evaluation of Utility Measurement in Crohnʼs Disease
Gregor, J. C., McDonald, J. W., Klar, N. S., Wall, R., Atkinson, K., Lamba, B., & Feagan, B. G. (1997) · Inflammatory Bowel Diseases · doi:10.1002/ibd.3780030405 · Cited by 158
Sidler, M. A., Leach, S. T., & Day, A. S. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20336 · Cited by 154
Faecal Calprotectin: A Novel Test for the Diagnosis of Colorectal Cancer?
Røseth, A. G., Kristinsson, J. A., Fagerhol, M. K., Schjønsby, H., Aadland, E., Nygaard, K., & Roald, B. (1993) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529309098312 · Cited by 154
Irritable bowel syndrome: the view from general practice
Thompson, G. W., Heaton, K. W., Smyth, T. G., & Smyth, C. (1997) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-199707000-00008 · Cited by 145
Crohn’s Disease and Ulcerative Colitis Are Associated With Elevated Standardized Mortality Ratios
Bewtra, M., Kaiser, L., Tenhave, T., & Lewis, J. D. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e31827f27ae · Cited by 140
Burgmann, T., Clara, I., Graff, L., Walker, J., Lix, L., Rawsthorne, P., McPhail, C., Rogala, L., Miller, N., & Bernstein, C. N. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.03.003 · Cited by 135
Perminow, G., Brackmann, S. A., Lyckander, L. G., Franke, A., Borthne, A., Rydning, A., Aamodt, G., Schreiber, S., Vatn, M. H., & The IBSEN-II Group (2009) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520802647434 · Cited by 132
Ford, A. C., Talley, N. J., van Zanten, S. J. O. V., Vakil, N. B., Simel, D. L., & Moayyedi, P. (2008) · JAMA · doi:10.1001/jama.300.15.1793 · Cited by 130
Canani, R. B., de Horatio, L. T., Terrin, G., Romano, M. T., Miele, E., Staiano, A., Rapacciuolo, L., Polito, G., Bisesti, V., Manguso, F., et al. (2005) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/01.mpg.0000187818.76954.9a · Cited by 129
Growth retardation in pediatric Crohnʼs disease
Shamir, R., Phillip, M., & Levine, A. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20115 · Cited by 128
Turner, D., Leach, S. T., Mack, D. R., Uusoue, K., McLernon, R., Hyams, J. S., LeLeiko, N. S., Walters, T. D., Crandall, W., Markowitz, J. F., et al. (2010) · Gut · doi:10.1136/gut.2010.211755 · Cited by 127
Fagerberg, U. L., Lööf, L., Lindholm, J., Hansson, L., & Finkel, Y. (2007) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e31810e75a9 · Cited by 125
Validation of the EuroQol questionnaire in patients with inflammatory bowel disease
König, H., Ulshöfer, A., Gregor, M., von Tirpitz, C., Reinshagen, M., Adler, G., & Leidl, R. (2002) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200211000-00008 · Cited by 121
Clinical value of fecal calprotectin in determining disease activity of ulcerative colitis
Xiang, J.-Y., Ouyang, Q., Li, G., & Xiao, N. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.53 · Cited by 119
Utility of red flag symptom exclusions in the diagnosis of irritable bowel syndrome
WHITEHEAD, W. E., PALSSON, O. S., FELD, A. D., LEVY, R. L., VON KORFF, M., TURNER, M. J., & DROSSMAN, D. A. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.02956.x · Cited by 118
Henderson, P., Casey, A., Lawrence, S. J., Kennedy, N. A., Kingstone, K., Rogers, P., Gillett, P. M., & Wilson, D. C. (2012) · The American Journal of Gastroenterology · doi:10.1038/ajg.2012.33 · Cited by 116
Ricanek, P., Brackmann, S. A., Perminow, G., Lyckander, L. G., Sponheim, J., Holme, Ø., Høie, O., Rydning, A., Vatn, M. H., & THE IBSEN II STUDY GROUP (2011) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2011.584897 · Cited by 115
Review of Fecal Biomarkers in Inflammatory Bowel Disease
Sutherland, A. D., Gearry, R. B., & Frizelle, F. (2008) · Diseases of the Colon & Rectum · doi:10.1007/s10350-008-9310-8 · Cited by 113
Validity, reliability, and responsiveness of the EQ-5D in inflammatory bowel disease in Germany
Stark, R. G., Reitmeir, P., Leidl, R., & König, H. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20989 · Cited by 112
Between-assay variability of faecal calprotectin enzyme-linked immunosorbent assay kits
Whitehead, S. J., French, J., Brookes, M., Ford, C., & Gama, R. M. (2012) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/acb.2012.011272 · Cited by 111
Fecal calprotectin is equally sensitive in Crohn's disease affecting the small bowel and colon
Jensen, M. D., Kjeldsen, J., & Nathan, T. (2011) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2011.560680 · Cited by 109
Aomatsu, T., Yoden, A., Matsumoto, K., Kimura, E., Inoue, K., Andoh, A., & Tamai, H. (2011) · Digestive Diseases and Sciences · doi:10.1007/s10620-011-1633-y · Cited by 107
Jellema, P., van der Windt, D., Schellevis, F., & van der Horst, H. E. (2009) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2009.04087.x · Cited by 102
Long-term health outcomes in pediatric inflammatory bowel disease: A population-based study
Turunen, P., Ashorn, M. H., Auvinen, A. P., Iltanen, S., Huhtala, H., & Kolho, K. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20558 · Cited by 99
Dolwani, S., Metzner, M., Wassell, J., Yong, A., & Hawthorne, A. B. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.02128.x · Cited by 99
Schröder, O., Naumann, M., Shastri, Y., Povse, N., & Stein, J. M. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03457.x · Cited by 98
Cost-utility of initial medical management for Crohn's disease perianal fistulae
Arseneau, K. O., Cohn, S. M., Cominelli, F., & Connors, A. F. (2001) · Gastroenterology · doi:10.1053/gast.2001.24884 · Cited by 96
Manz, M., Burri, E., Rothen, C., Tchanguizi, N., Niederberger, C., Rossi, L., Beglinger, C., & Lehmann, F. S. (2012) · BMC Gastroenterology · doi:10.1186/1471-230x-12-5 · Cited by 95
Accuracy of Four Fecal Assays in the Diagnosis of Colitis
Schoepfer, A. M., Trummler, M., Seeholzer, P., Criblez, D., & Seibold, F. (2007) · Diseases of the Colon & Rectum · doi:10.1007/s10350-007-0303-9 · Cited by 93
A Novel Tool for Noninvasive Diagnosis and Tracking of Patients with Inflammatory Bowel Disease
Arasaradnam, R. P., Ouaret, N., Thomas, M. G., Quraishi, M. N., Heatherington, E., Nwokolo, C. U., Bardhan, K. D., & Covington, J. A. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e3182802b26 · Cited by 91
Self-citationKok, L., Elias, S. G., Witteman, B. J. M., Goedhard, J. G., Muris, J. W. M., Moons, K. G. M., & de Wit, N. J. (2012) · Clinical Chemistry · doi:10.1373/clinchem.2011.177980 · Cited by 89
Pavlidis, P., Chedgy, F., & Tibble, J. A. (2013) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2013.816771 · Cited by 88
Ford, A. C., & Talley, N. J. (2012) · BMJ · doi:10.1136/bmj.e5836 · Cited by 87
Burden of Illness in Irritable Bowel Syndrome Comparing Rome I and Rome II Criteria
Badia, X. C., Mearin, F., Balboa, A., Bär, E., Caldwell, E., Cucala, M., Díaz‐Rubio, M., Fueyo, A., Ponce, J. D. C., Roset, M., et al. (2002) · PharmacoEconomics · doi:10.2165/00019053-200220110-00004 · Cited by 84
Damms-Machado, A., & Bischoff, S. C. (2008) · International Journal of Colorectal Disease · doi:10.1007/s00384-008-0506-0 · Cited by 83
Otten, C. M. T., Kok, L., Witteman, B. J. M., Baumgarten, R., Kampman, E., Moons, K. G. M., & de Wit, N. J. (2008) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2008.246 · Cited by 83
Fecal Calprotectin and Lactoferrin as Noninvasive Markers of Pediatric Inflammatory Bowel Disease
Joishy, M., Davies, I. H., Ahmed, M., Wassell, J., Davies, K., Sayers, A. E., & Jenkins, H. R. (2009) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e31816533d3 · Cited by 81
Grogan, J., Casson, D. H., Terry, A., Burdge, G. C., El‐Matary, W., & Dalzell, M. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21690 · Cited by 80
Hoff, G. S., Grotmol, T., Thiis‐Evensen, E., Bretthauer, M., Gondal, G., & Vatn, M. H. (2004) · Gut · doi:10.1136/gut.2004.039032 · Cited by 80
Ashorn, S., Honkanen, T., Kolho, K., Ashorn, M. H., Välineva, T., Wei, B., Braun, J. G., Rantala, I. S., Luukkaala, T. H., & Iltanen, S. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20535 · Cited by 78
Buxton, M. J., Lacey, L. A., Feagan, B. G., Niecko, T., Miller, D. W., & Townsend, R. J. (2007) · Value in Health · doi:10.1111/j.1524-4733.2007.00171.x · Cited by 78
Risk of inflammatory bowel disease following a diagnosis of irritable bowel syndrome
Porter, C. K., Cash, B. D., Pimentel, M., Akinseye, A., & Riddle, M. S. (2012) · BMC Gastroenterology · doi:10.1186/1471-230x-12-55 · Cited by 78
Faecal markers of gastrointestinal inflammation
Sherwood, R. A. (2012) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2012-200901 · Cited by 77
Spiegel, B. M. R., Harris, L. A., Lucak, S. L., Mayer, E. A., Naliboff, B. D., Bolus, R. R., Esrailian, E., Chey, W. D., Lembo, A. J., Karsan, H. A., et al. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.232 · Cited by 74
Naismith, G., Smith, L., Barry, S., Munro, J. I., Laird, S., Rankin, K., Morris, A., Winter, J., & Gaya, D. R. (2013) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12221 · Cited by 71
Defective Paneth Cell—Mediated Host Defense in Pediatric Ileal Crohn's Disease
Perminow, G., Beisner, J., Koslowski, M. J., Lyckander, L. G., Stange, E. F., Vatn, M. H., & Wehkamp, J. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.643 · Cited by 70
Fecal Calprotectin in Pediatric Inflammatory Bowel Disease: A Systematic Review
Kostakis, I. D., Cholidou, K. G., Vaiopoulos, G., Vlachos, I. S., Perrea, D. N., & Vaos, G. (2012) · Digestive Diseases and Sciences · doi:10.1007/s10620-012-2347-5 · Cited by 69
Faecal calprotectin in children with chronic gastrointestinal symptoms
Bremner, A., Roked, S., Robinson, R., Phillips, I., & Beattie, M. (2005) · Acta Paediatrica · doi:10.1111/j.1651-2227.2005.tb01870.x · Cited by 68
The burden of inflammatory bowel disease on health care utilization and quality of life
Nurmi, E., Haapamäki, J., Paavilainen, E., Rantanen, A., Hillilä, M., & Arkkila, P. (2013) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2012.685750 · Cited by 66
Sydora, M. J., Sydora, B. C., & Fedorak, R. N. (2011) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2011.08.008 · Cited by 66
Gibson, P. R., Weston, A. R., Shann, A., Florin, T. H., Lawrance, I. C., Macrae, F., & Radford‐Smith, G. L. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.04930.x · Cited by 64
Schoepfer, A. M., Vavricka, S. R., Zahnd, N., Straumann, A., & Beglinger, C. (2011) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2011.09.008 · Cited by 63
Faecal calprotectin – a useful tool in the management of inflammatory bowel disease
Burri, E., & Beglinger, C. (2012) · Swiss Medical Weekly · doi:10.4414/smw.2012.13557 · Cited by 61
The impact of Irritable Bowel Syndrome on health-related quality of life: a Singapore perspective
Wang, Y. T., Lim, H. Y., Tai, D. W.-M., Krishnamoorthy, T. L., Tan, T. J., Barbier, S., & Thumboo, J. (2012) · BMC Gastroenterology · doi:10.1186/1471-230x-12-104 · Cited by 59
Meucci, G., Renata D'Incà, Maieron, R., Orzes, N., Vecchi, M., Visentini, D., Minoli, G., Pont, E. D., Zilli, M., Benedetti, E., et al. (2009) · Digestive and Liver Disease · doi:10.1016/j.dld.2009.07.002 · Cited by 58
A new rapid home test for faecal calprotectin in ulcerative colitis
Elkjær, M., Burisch, J. M., Hansen, V. V., Kristensen, B. D., JENSEN, J. ‐. S., & Munkholm, P. (2009) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2009.04164.x · Cited by 53
Diagnostic work-up of inflammatory bowel disease in children: The role of calprotectin assay
Diamanti, A., Panetta, F., Basso, M. S., Forgione, A., Colistro, F., Bracci, F., Papadatou, B., Francalanci, P., Torroni, F., Knafelz, D., et al. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21257 · Cited by 52
Mindemark, M., & Larsson, A. O. (2011) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2011.10.015 · Cited by 52
Jelsness‐Jørgensen, L., Bernklev, T., & Moum, B. A. (2013) · Gastroenterology Research and Practice · doi:10.1155/2013/620707 · Cited by 51
Limitations of Fecal Calprotectin At Diagnosis in Untreated Pediatric Crohnʼs Disease
Shaoul, R. R., Sładek, M., Turner, D., Pærregaard, A., Veres, G., Wauters, G. V., Escher, J. C., Dias, J. A., Lionetti, P., Staino, A., et al. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21875 · Cited by 49
Splitting Irritable Bowel Syndrome: From Original Rome to Rome II Criteria
Mearin, F., Roset, M., Badia, X. C., Balboa, A., Baró, E., Ponce, J. D. C., Díaz‐Rubio, M., Caldwell, E., Cucala, M., Fueyo, A., et al. (2004) · The American Journal of Gastroenterology · doi:10.1046/j.1572-0241.2003.04024.x · Cited by 48
Ananthakrishnan, A. N., Korzenik, J. R., & Hur, C. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.22951 · Cited by 48
Fecal calprotectin: assessment of a rapid test
Vestergaard, T., Nielsen, S. L., Dahlerup, J. F., & Hornung, N. (2008) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365510701576198 · Cited by 47
Inflammatory bowel disease: a systematic review on the value of diagnostic testing in primary care
Jellema, P., van Tulder, M. W., van der Horst, H. E., Florie, J., Mulder, C. J. J., & van der Windt, D. (2009) · Colorectal Disease · doi:10.1111/j.1463-1318.2009.02131.x · Cited by 46
Quality of Life in Children With Crohn Disease
Hill, R. J., Lewindon, P. J., Muir, R., Grange, I., Connor, F. L., Ee, L. C., Withers, G. D., Cleghorn, G. J., & Davies, P. (2010) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e3181c2c0ef · Cited by 44
Rapid Test for Fecal Calprotectin Levels in Children With Crohn Disease
Kolho, K., Turner, D., Veereman‐Wauters, G., Sładek, M., de Ridder, L., Shaoul, R. R., Pærregaard, A., Dias, J. A., Koletzko, S., Nuti, F., et al. (2012) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e318253cff1 · Cited by 43
Casellas, F., Rodrigo, L., Niño, P., Pantiga, C., Riestra, S., & Malagelada, J. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20205 · Cited by 43
van Rheenen, P. F. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.22896 · Cited by 41
The standard gamble showed better construct validity than the time trade-off
Puhan, M. A., Schünemann, H. J., Wong, E. Y. L., Griffith, L. E., & Guyatt, G. H. (2007) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2007.03.001 · Cited by 40
Burri, E., Manz, M., Rothen, C., Rossi, L., Beglinger, C., & Lehmann, F. S. (2012) · Clinica Chimica Acta · doi:10.1016/j.cca.2012.11.008 · Cited by 32
Flagstad, G., Helgeland, H., & Markestad, T. (2010) · Acta Paediatrica · doi:10.1111/j.1651-2227.2010.01698.x · Cited by 31
Haapamäki, J., Tanskanen, A. J., Roine, R. P., Blom, M., Turunen, U., Mäntylä, J., Färkkilä, M. A., & Arkkila, P. E. T. (2012) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2012.743584 · Cited by 30
Komraus, M., Woś, H., Więcek, S., et al. (2012) · Mediators of Inflammation · doi:10.1155/2012/608249 · Cited by 30
Implementing changes in clinical practice to improve the management of Crohn's disease
Panaccione, R., Hibi∥, T., Peyrin‐Biroulet, L., & Schreiber, S. (2012) · Journal of Crohn s and Colitis · doi:10.1016/s1873-9946(12)60503-0 · Cited by 28
Connolly, M. P., Poole, C., Currie, C. J., Marteau, P. R., & Nielsen, S. K. (2009) · Digestion · doi:10.1159/000235916 · Cited by 27
Calprotectina fecal como marcador diferencial entre patología gastrointestinal orgánica y funcional
Tomàs, A. B., Vidal, M. V., & Camps, A. R. (2007) · Revista Española de Enfermedades Digestivas · doi:10.4321/s1130-01082007001200002 · Cited by 27
Waljee, A. K., Higgins, P., Waljee, J. F., Tujios, S. R., Saxena, A., Admon, L. K., Chaudhary, M. N., & Morris, A. M. (2011) · The American Journal of Gastroenterology · doi:10.1038/ajg.2011.39 · Cited by 26
Burden of Crohn’s disease: economics and quality of life aspects in Italy
Colombo, G., Benedini, V., Caporaso, N., Corazza, G. R., Rossi, Z., Fornaciari, G., Cottone, M., Frosini, G., Chiara, O., & Caruggi, M. (2012) · ClinicoEconomics and Outcomes Research · doi:10.2147/ceor.s31114 · Cited by 23
Poole, C. D., Connolly, M. P., Nielsen, S. K., Currie, C. J., & Marteau, P. (2010) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2009.11.010 · Cited by 23
Fecal Calprotectin as a Predictor of Abnormal Colonic Histology
Shitrit, A. B., Braverman, D. Z., Stankiewics, H., Shitrit, D., Peled, N., & Paz, K. (2007) · Diseases of the Colon & Rectum · doi:10.1007/s10350-007-9038-x · Cited by 21
Impact of colonoscopy on quality of life
Niv, Y., Bogolavski, I., Ilani, S., Avni, I., Gal, E., Vilkin, A., & Levi, Z. (2012) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e328352deff · Cited by 21
DiBonaventura, M., Prior, Prieto, V., & Fortea (2012) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s35568 · Cited by 17
Bracco, A., Jönsson, B., Ricci, J.-F., Drummond, M., & Nyhlin, H. (2007) · Value in Health · doi:10.1111/j.1524-4733.2007.00179.x · Cited by 17
Turvill, J. L. (2011) · Frontline Gastroenterology · doi:10.1136/flgastro-2011-100011 · Cited by 17
Faecal calprotectin in differentiating between functional and organic bowel diseases
El-Badry, A., Sedrak, H. K., & Rashed, L. (2010) · Arab Journal of Gastroenterology · doi:10.1016/j.ajg.2010.04.009 · Cited by 14
Waters, H. C., Vanderpoel, J., Nejadnik, B., McKenzie, R. S., Lunacsek, O. E., Lennert, B. J., Goff, J. S., & Augustyn, D. H. (2011) · Journal of Medical Economics · doi:10.3111/13696998.2011.625746 · Cited by 12
Shastri, Y., Povse, N., & Stein, J. M. (2009) · PubMed · Cited by 10
Lee, S. H., Mainman, H., Borthwick, H., & Dhar, A. (2013) · Gut · doi:10.1136/gutjnl-2013-304907.581 · Cited by 6
Hornung, T. A., & Anwar, G. A. (2011) · Gut · doi:10.1136/gut.2011.239301.427 · Cited by 1
Cited by
Lacy, B. E., Mearin, F., Chang, L., Chey, W. D., Lembo, A. J., Simren, M., & Spiller, R. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.031 · Cited by 2,866
Ulcerative Colitis in Adults: A Review
Gros, B., & Kaplan, G. G. (2023) · JAMA · doi:10.1001/jama.2023.15389 · Cited by 738
Saez-Lara, M. J., Gomez-Llorente, C., Plaza-Diaz, J., & Gil, A. (2015) · BioMed Research International · doi:10.1155/2015/505878 · Cited by 388
Arasaradnam, R. P., Brown, S., Forbes, A., Fox, M. R., Hungin, P., Kelman, L., Major, G., O’Connor, M., Sanders, D. S., Sinha, R., et al. (2018) · Gut · doi:10.1136/gutjnl-2017-315909 · Cited by 332
Self-citationDiagnosis of Irritable Bowel Syndrome: Role of Potential Biomarkers
Plavšić, I., Hauser, G., Tkalčić, M., Pletikosić, S., & Salkić, N. (2015) · Gastroenterology Research and Practice · doi:10.1155/2015/490183 · Cited by 37
Metadata
- Authors
- Waugh, N., Cummins, E., Royle, P., Kandala, N.-B., Shyangdan, D., Arasaradnam, R., Clar, C., & Johnston, R.
- Venue
- Health Technology Assessment
- Published
- 2013-11
- Volume
- 17
- Issue
- 55
- Pages
- xv-xix, 1
- ISSN
- 1366-5278 (ISSN-L)
- 2046-4924
- OpenAlex
- W2061080474
- Cited by
- 286
- References
- 155
- FWCI
- 2.89
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.